ClinicalTrials.Veeva

Menu

Pathological Results of Aggressive Hepatocellular Carcinomas Treated Using SIRT (PAHCHS)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

Hepatocellular Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT05045573
RECHMPL21_0557

Details and patient eligibility

About

The aim of our study is to analyze pathological analysis of surgically treated aggressive hepatocellular carcinomas after radio-embolization.

The investigators aim to demonstrate that a higher dose results in better tumor response while respecting safety conditions, that is, no radiologically induced liver disease.

Enrollment

28 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • aggressive hepatocellular carcinomas with vascular invasion, large tumors or multifocal distribution

Exclusion criteria

  • Other treatment after SIRT (confounding effect)
  • contraindications for surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems